| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.48 | 0.01 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |